BioNTech SE (BNTX) FCF Margin (2018 - 2025)
BioNTech SE's (BNTX) quarterly FCF Margin came in at 41.07% in Q4 2025, up 4109.0% year-on-year from 0.98% in Q4 2024, and down 23.6% quarter-over-quarter from 53.76% in Q3 2025.
BioNTech SE (BNTX) FCF Margin (2018 - 2025) Analysis & Trends
BioNTech SE has disclosed FCF Margin across 8 years of filings, most recently posting 41.07% for Q4 2025.
- FCF Margin for Q4 2025 came in at 41.07%, up 4109.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 28.45% (up 2844.0% YoY), and the FY2025 annual result was 840.35%, up 82238.0% from the prior year.
- FCF Margin came in at 41.07% for Q4 2025 at BioNTech SE, down from 53.76% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 2655.87% in Q2 2023 to a low of 3154.31% in Q1 2025.
- The 5-year median for FCF Margin is 33.59% (2021), against an average of 39.58%.
- Across the five-year window, FCF Margin jumped 253106 bps in 2023 and plunged 276354 bps in 2024, its largest moves.
- BioNTech SE's FCF Margin stood at 4.32% in 2021, then jumped by 423 bps to 22.57% in 2022, then soared by 180 bps to 63.2% in 2023, then tumbled by 100 bps to 0.01% in 2024, then surged by 341774 bps to 41.07% in 2025.
- The last three FCF Margin figures came in at 41.07% (Q4 2025), 53.76% (Q3 2025), and 2225.64% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | 41.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.07% |
| Sep 30, 2025 | 53.76% |
| Jun 30, 2025 | 2,225.64% |
| Mar 31, 2025 | -3,154.31% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -45.48% |
| Jun 30, 2024 | 1,333.18% |
| Mar 31, 2024 | -2,813.04% |
| Dec 31, 2023 | 63.20% |
| Sep 30, 2023 | 96.55% |
| Jun 30, 2023 | 2,655.87% |
| Mar 31, 2023 | -49.51% |
| Dec 31, 2022 | 22.57% |
| Sep 30, 2022 | 140.32% |
| Jun 30, 2022 | 124.81% |
| Mar 31, 2022 | 64.23% |
| Dec 31, 2021 | 4.32% |
| Sep 30, 2021 | 26.10% |
| Jun 30, 2021 | 2.38% |
| Mar 31, 2021 | 0.00% |